Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients.

Experimental dermatology - 1 Nov 2013

Ganzenmueller Tina, Hage Elias, Yakushko Yuri, Kluba Jeanette, Woltemate Sabrina, Schacht Vivien, Schulz Thomas F, Gutzmer Ralf

Abstract excerpt

Patients treated with BRAF inhibitors (e.g. vemurafenib), a novel targeted therapy for advanced melanoma harbouring certain BRAF mutations, develop numerous adverse cutaneous side effects, including skin tumors such as squamous cell carcinoma or non-malignant verruciform keratinocyte proliferations, termed 'BRAF-inhibitor-associated verrucous keratosis (BAVK) lesions'. These keratinocyte proliferations are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Gene Library

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indoles

Share to Keratinocytes

Share to Papillomaviridae

Share to Skin Neoplasms

Share to Sulfonamides

Share to Vemurafenib

Source

Identifiers

PMID: 24112647
DOI: 10.1111/exd.12249

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients.PMID 24112647Read ↗

Next‐generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinomaSemantic proximity Read ↗

Human Skin Microbiota: High Diversity of DNA Viruses Identified on the Human Skin by High Throughput SequencingSemantic proximity Read ↗

Unbiased Approach for Virus Detection in Skin LesionsSemantic proximity Read ↗

Human papillomavirus-negative epithelial proliferations resembling condylomata acuminata in a patient receiving vemurafenib for Stage IV melanoma.Semantic proximity Read ↗

High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib.Semantic proximity Read ↗

Erdheim-Chester disease associated with a novel, complex BRAF p.Thr599_Val600delinsArgGlu mutation.Semantic proximity Read ↗

Vemurafenib-associated keratoses with genetic heterogeneity of RAS.Semantic proximity Read ↗

Human papillomavirus type 197 is commonly present in skin tumorsSemantic proximity Read ↗

Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma.Semantic proximity Read ↗

Chicken skin virome analyzed by high-throughput sequencing shows a composition highly different from human skinSemantic proximity Read ↗

Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.Semantic proximity Read ↗

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.